Search Records

Individual facilities with a specific geographic location for each reporting BC Greenhouse Gas Emissions. Part of the set of data for Industrial Facility Greenhouse Gas Emission Summaries as currently published for 2010, 2011, 2012 and 2013 by the Director under authority of s.29 of the Reporting...

Summaries of emission reports for electricity import operations. Part of the set of data for Industrial Facility Greenhouse Gas Emission Summaries as currently published for 2010, 2011, 2012 and 2013 by the Director under authority of s.29 of the Reporting Regulation (under authority of the...

A medical device is any instrument or component used to treat, diagnose or prevent a human disease or abnormal physical condition. Page about what medical device problems are and how to report them.

Health Canada information related to adverse reaction reporting of drugs and health products on the Canadian market

Staffing Update Report: April 2022- September 2022

A list of current standard projects at various stages of development and demonstrates Canadian General Standards Board compliance to the World Trade Organization (WTO) Agreement on "Technical Barriers to Trade".

Opioid agonist treatment (OAT) is an effective treatment for opioid use disorder (OUD) as it prevents withdrawal symptoms, reduces cravings, and has been associated with beneficial outcomes such as reductions in illicit drug use and related harms (e.g., overdose, mortality, etc.). To better...

Correctional populations experience high levels of opioid use disorder (OUD) and increased risks for related harms upon the high-risk period of community release and reintegration, including overdose and premature mortality. Opioid agonist therapy (OAT) is an effective treatment for OUD and its...

A list of all the links that are broken on the Open Government Portal

This report, which is tabled under section 20 of the Service Fees Act and section 4.2.8 of the Directive on Charging and Special Financial Authorities, contains information about the fees that Health Canada had the authority to charge in the 2022-23 fiscal year.